The road to creativity New York Social Diary

Wednesday, November 3, 2021. Colder and rainy with temperatures in the low 50s yesterday in New York, falling to the low 40s at night. Time for the winter jackets to come out of the closet.

Jane Lahr with a copy of The Radiant Tarot: Pathway to Creativity. Click to order.

I had breakfast yesterday with Jane Lahr, a literary agent, an old friend promoting a new book, The Radiant Tarot: Pathway to Creativity by Alexandra Eldridge and Tony Barnstone which will be celebrated at a book party at Rizzoli tonight. The book, which is beautifully bound and framed, is “a richly painted at times stunning, fine art images of plants, animals and people living with a dream like the world that leads tarot readers down a glorious path of awakened creativity and personal growth. . ”

If you now know nothing about the tarot (and although I’m vaguely aware of it, I’m basically with you on it) when I just heard about it from Jane yesterday, and saw the book and a game with 78 beautiful maps, was fascinated. There is more to learn and after debuting tonight at Rizzoli I hope I can tell you more.

In the meantime: The Alzheimer’s Drug Discovery Foundation (ADDF) is hosting its 12th annual fall symposium and lunch pretty much last Thursday, October 28th. The event raised $ 1.2 million for drug development research to prevent, treat and cure Alzheimer’s disease. The event featured ADDF co-founders and co-chairmen Leonard Lauder and Ronald Lauder.

Hosted by journalist and ADDF board member Paula Zahn, the celebration honored Howard Kaneff, President Emeritus, and Mitchell Kaneff, Chairman and CEO of Arkay Packaging, with Charles Evans Award for Management. Also rewarded with Melvin R. Goodes Prize was Miia Kivipelto, MD, PhD, Professor of Clinical Geriatrics at Karolinska Institutet, Center for Alzheimer’s Research and Senior Geriatrics and Director of Research and Development of Thematic Aging at Karolinska University Hospital, Stockholm, Sweden.

Paula Zahn and Leonard Lauder.
Ronald S. Lauder.

Arkay is a three-generation family-run company that has been supplying packaging to the cosmetics, pharmaceutical and health and beauty industries, including the Estee Lauder Companies, for more than nine decades. Kaneffs are both valued supporters of the ADDF, and Mitchell currently serves on the ADDF Board of Supervisors.

Leonard Lauder praised them and their decades of support. “I have known Howard and Mitchell for decades, both as dear friends and respected business partners. When Howard’s late wife and Mitchell’s mother, Cherry, began to experience Alzheimer’s symptoms, there was no definitive way to get a diagnosis. “Thanks to ADDF and the support of steadfast supporters like Kaneffs, that is no longer the case – we now have the diagnostic tools to give patients and families the answers they deserve.”

Josh Kaneff, Mitchell Kaneff, Viviane Kaneff, Howard Kaneff and Max Kaneff.
Alice Shure, Mitchell Kaneff and Bonnie Pfeifer Evans.

“I’m incredibly honored and humbled,” said Mitchell Kaneff, “as I know my father is – to accept 2021 Charles Evans Award. As an ADDF board member and a person who lost a loved one to Alzheimer’s, I am grateful to be part of an organization that plays a key role in advancing new diagnostic tools and therapies. “

“When I heard we were going to receive it Charles Evans Award, I was thrilled, ”Howard added. “I first became acquainted with ADDF through my dear friend Leonard Lauder over twenty years ago, and today my son is on the board and plays a key role in providing financial support for further critical research.”

Alan Patricof, Bonnie Evans, William Lauder and Bonnie Lautenberg.
Howard Kaneff, Mitchell Kaneff and Leonard A. Lauder.

Dr. Miia Kivipelto awarded the Melvin R. Goodes Prize 2021 for Innovative Research. This is an annual award given to leading researchers who make important progress towards the development of effective treatments and a cure for Alzheimer’s. The Goodes Prize was established in 2015 by Mr. Goodes, an honorary member of the ADDF Board of Governors, and Nancy Goodes, member of ADDF’s Board of Directors. That Premium includes a $ 150,000 prize and will support Dr. Kivipeltos continued research into the prevention, early diagnosis and treatment of cognitive impairment, dementia and Alzheimer’s disease.

Introducing the award, Nancy Goodes said, “When we first launched the award, our goal was to honor Mel and his legacy in the field of drug development, while supporting groundbreaking science that ADDF advocates. This award does just that. We are pleased to present this year’s award. to Dr. Kivipelto, whose monumental work on the FINGER trial has changed the way we look at lifestyle interventions to prevent Alzheimer’s. “

Dr. Miia Kivipelto.

Dr. Kivipelto expressed his gratitude: “On behalf of my team and I, I am incredibly honored to receive such a prestigious recognition, which also provides validation for the multi-domain prevention model, which addresses both several risk factors and mechanisms. This award is especially important as Mel “Goodes, a prominent leader in the pharmaceutical industry, and his work have had a positive impact on several patients. Receiving an award in Mel and Nancy’s name is an inspiration as we continue our research into Alzheimer’s prevention.”

Moderated by the ADDFs Chief Executive Officer and Chief Science Officer, Dr. Howard Fillit, Dr. Kivipelto joined another notable scientist at the annual symposium – Miranda Orr, PhD, Assistant Professor of Gerontology and Geriatric Medicine at the Wake Forest School of Medicine – for a panel entitled State of Alzheimer’s Prevention: What Can You Do Today?

Dr. Howard Fillit, Jane McIntosh, Leonard A. Lauder and Mark Roithmayr.

The autumn symposium and lunch would not have been possible without the generous support of many contributors and donors: including: Melanie Goodes Caceres, The Estée Lauder Companies Inc., Nancy and Melvin R. Goodes, Kiera and Christopher Johnson, Howard Kaneff, Mitchell Kaneff, Judy and Leonard A. Lauder, Gary and Laura Lauder, William P. Lauder and Lori Kanter Tritsch, Jo Carole and Ronald S. Lauder, Susan and Tom Lowder, Samuel I. Newhouse Foundation, Sharon T. Sager and J. Loring Swasey, Liz and Randal Sandler, and David R. Weinreb.

ADDF was founded in 1998 by the Lauder brothers Leonard and Ronald Lauder. The foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer’s disease. It is the only public charity that focuses exclusively on funding the development of drugs for Alzheimer’s, using a venture philanthropy model to support research in academia and the biotechnology industry.

Through the generosity of its donors, ADDF has allocated more than $ 168 million to fund more than 650 Alzheimer’s and related dementia programs in academic centers and biotechnology companies in 19 countries. To learn more, please visit

Leave a Comment